Scientific Federation conducting World Congress on gynecology & Obstetrics at Toronto, Canada which will be held on September 20-21, 2018.

Theme of the conference: Expedite the Future Endeavour’s in Gynecology and Obstetrics Care
For more details about the conference: http://scientificfederation.com/gynecology-2018/
It is a two days conference will provoke plenary sessions, Keynote speeches, Poster, and Oral presentations.
To register: http://scientificfederation.com/gynecology-2018/registration.php
Earlybird Registration on/before February 28, 2018
Standard Registration on/before May 25, 2018
On Spot Registration on September 20, 2018
All Abstracts Will be Published on the Conference Book
Abstract Submission deadline is August 30, 2018
Abstract Submission link: http://scientificfederation.com/gynecology-2018/abstract-submission.php
Scientific Sessions include:-
·         Reproductive Medicine
·         IVF
·         Family planning
·         Polycystic Ovarian Syndrome
·         Epidemiology of Gynecologic Cancers
·         Gynecological Oncology
·         Primary Peritoneal Cancer
·         Quality of Life of Patients with Gynecologic Cancers
·         Reproductive Cancer
·         Socio- Psychological Aspects of Gynecological Cancers
·         Targeted Molecular Therapy for all Gynecologic Cancers
·         Cesarean Delivery
·         Polycystic Ovary Syndrome
·         Pregnancy
·         Pregnancy Diabetes
·         Obstetrics and Gynecology
·         Minimally Invasive Gynecology
·         Gynecological Diagnosis and Treatment
·         Gynecological issues
·         Advanced laparoscopic surgery
·         Post term pregnancy
·         Ultrasound in Obstetrics and Gynecology
·         Pediatric and adolescent gynecology
·         Menopausal and geriatric gynecology
·         Obstetric Nursing
·         Obstetric Fistula
·         Gynecology and Fertility
·         Gynecological Cancer
·         Reproductive Gynecology
·         Maternal-fetal medicine
Our Plenary speakers are
Ø  JoAnn E. Manson
                Harvard Medical School, USA
Ø  Horvath, Steve
               University of California, USA
Ø  Mark Kilby
               University of Birmingham, UK
Ø  Panos Zavos
     University of Minnesota, USA
Ø  Luca Gianaroli
Chairmen of the Board of SISME, Italy
For Organizing Committee members: http://scientificfederation.com/gynecology-2018/organizing-committee.php

We are planning to conduct workshop on In vitro fertilization
Did you know that there are 6.7 million women suffering from infertility today in the US alone? Yet, despite the increasing infertility rates, modern medicine has been quick to come up with solutions.

Even though studies of human embryology and developmental biology began in the 18th century, the most notable progress has occurred in just the last two to three decades.

Women having trouble conceiving can choose from a number of Assisted Reproductive Technologies (ARTs) such as: artificial insemination, in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT) and others. The IVF process is by far the most common.

There are a number of factors that can determine the outcome of the procedure. Age and fitness of the would-be mother can severely influence the IVF cycle. Though, despite being a fairly complicated process it remains relatively safe and it has lead to more than 5 million births worldwide.

If you’re considering using IVF or you want to work as an IVF technologist, learn more about this innovative technology below.

Lab-grown eggs could aid fertility treatments

                                                                        
Magnification of a lab-grown, fully matured human egg ready for fertilization.
Scientists have grown egg cells, which were removed from ovary tissue at their earliest stage of development, to the point at which they are ready to be fertilised.

Egg storage
The advance could safeguard the fertility of girls with cancer ahead of potentially harmful medical treatment, such as chemotherapy.
Immature eggs recovered from patients’ ovarian tissue could be matured in the lab and stored for later fertilization.
Conventionally, cancer patients can have a piece of ovary removed before treatment, but reimplanting this tissue can risk reintroducing cancer.
The study has also given insight into how human eggs develop at various stages, which could aid research into other infertility treatments and regenerative medicine.
Developing cells
Scientists and medical experts worked together to develop suitable substances in which eggs could be grown – known as culture mediums – to support each stage of cell development.
Their findings, using tissue donated by women who were undergoing routine surgery, build on 30 years of research.
In previous studies, scientists had developed mouse eggs to produce live offspring, and had matured human eggs from a relatively late stage of development.
The latest study is the first time a human egg has been developed in the lab from its earliest stage to full maturity.

About the Venue
Holiday Inn Toronto International Airport
970 Dixon Road, Toronto, ON M9W 1J9, Canada




Best regards,
Organizing Committee members of the conference
Hans-Peter Steiner
Karl-Franzens-University of Graz,
Austria
Seang Lin Tan
McGill University, Canada
EmadDarwish
Alexandria University, Egypt
Gamal Sayed
The University of Dundee, United
Kingdom
Stergios Doumouchtsis
Epsom & St Helier University Hospitals

0 comments:

Cesarean Delivery


This comprehensive analysis systematically reviewed 60 authoritative studies related to postpartum VTE outcomes. Investigators found that CS carries a fourfold greater VTE risk than VD. "We found that CS is an important independent risk factor for the development of VTE in the postpartum period and that approximately three VTE will occur for everything 1,000 CS performed, with greater risks for nonscheduled emergency CS," said lead investigator Marc Blondon, MD, Division of Angiology and Hemostasis, Geneva University Hospitals, Geneva Switzerland. These risks were largely independent of other factors like maternal age and body mass index.
Pregnant women become more susceptible to VTE due to a variety of factors, including venous stasis and trauma associated to delivery. Also, hemostatic changes drive increases in some coagulation factors, while decreasing bleeding inhibitors, but for some reason these changes seem to be worse for women who deliver via CS. "In the postpartum period specifically, women following CS exhibit greater activation of coagulation than women following VD, as reflected by greater D-dimer levels," explained Dr. Blondon. D-dimer levels indicate that blood clots may be forming or breaking down in the body. "This outcome may be a result of the conditions leading to the CS or to the procedure itself, similar to the increased VTE risk following non-obstetric surgery. Furthermore, physical activity is reduced following CS compared with following VD, with delayed recovery of mobility occurring in the first two days following delivery."
As with many non-obstetric surgical procedures, thromboprophylaxis, or preventive measures taken to try and stop VTE before it happens, is commonly employed to try and minimize risk; however, researchers found little evidence on the use of thromboprophylaxis after CS.
Key words: Cesarean Delivery, pregnancy.

0 comments:

Women health


"Women with only a small weight gain each year (1.5 to 2.5 per cent of body weight) doubled their risk of gestational diabetes,"
"Surprisingly, even women who were underweight or in the normal BMI range had an increased risk of gestational diabetes when they gained weight -- even if they remained within the healthy weight category.
"Women with small weight gains within the healthy BMI range doubled their risk of gestational diabetes compared to women whose weight remained stable."
Obesity is a known risk factor for gestational diabetes, which can lead to large babies, birth complications and long-term health risks for mothers and children.
Researchers set out to see what impact weight change had in the years leading up to pregnancy.
They tracked more than 3000 participants from the Women's Health Australia study (also known as the Australian Longitudinal Study on Women's Health).
The women, aged between 18 and 23 when they joined the study in 1996, have answered regular surveys on their weight, physical activity, lifestyle, health issues, and pregnancies ever since.
"It's important for women and their clinicians to be aware that, even in the healthy BMI range, gaining a kilogram or two a year can be a health risk,"
Key words: Diabetes, pregnancy, women health

URL: http://scientificfederation.com/gynecology-2018/

0 comments:

Stem cells


Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, the two currently available types of stem cell lines -- Embryonic Stem cells (ES) and induced Pluripotent Stem cells (iPS) -- have certain limitations. It is not currently possible for them to form every type of cell since they are already excluded from developing certain cell lineages.
To discover new stem cells for use in research and regenerative medicine, the researchers created a way of culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells that are still considered to retain some totipotency -- the ability to produce all cell types. Their hypothesis was that these cells should be less programmed than ES cells, which are taken from the around-100-cell stage of development -- called a blastocyst. They grew these early cells in a special growth condition that inhibited key development signals and pathways.
The scientists discovered that their new cultured cells kept the desired development characteristics of the earliest cells and named them Expanded Potential Stem Cells (EPSCs). Importantly, they were also able to reprogramme mouse ES cells and iPS cells in the new condition and create EPSCs from these cells, turning back the development clock to the very earliest cell type.
Key words: stem cells, egg, fertilization

URL: http://scientificfederation.com/gynecology-2018/


0 comments:


Scientific Federation is inviting you to participate in our worthwhile conference on Gynecology & Obstetrics on September 20-21, 2018 at Toronto, Canada.
Now a days Macrosomia -- large body size at birth -- is common among children born to obese women, particularly those who have gestational diabetes (high blood sugar during pregnancy). Macrosomia increases the risk that an infant will experience bone fracture during delivery. It also increases the likelihood that the infant will need to be delivered by cesarean section. Having a large infant also increases a mother's risk for postpartum hemorrhage, or excessive bleeding at birth.
In the current study, researchers analyzed ultrasound scans taken throughout pregnancy of more than 2,800 pregnant women: 443 obese women with no accompanying health conditions, such as diabetes, and more than 2300 non-obese women. The researchers categorized the women's weight according to their body mass index (BMI) score. Women with a BMI ranging from 30 to 44.9 were classified as obese, while those with a BMI of 29.9 were considered non-obese.
Beginning in the 21st week of pregnancy, ultrasound scans revealed that for fetuses of obese women, the femur (thigh bone) and humerus (upper arm bone) were longer than those of the fetuses of non-obese women. The differences between fetuses of obese and non-obese women continued through the 38th week of pregnancy.

Key words: fertility, pregnancy, ultrasound scan, birth


0 comments:

World Congress on Gynecology & Obstetrics-2018 at Toronto, Canada


Scientific Federation is inviting you to participate in our worthwhile conference on Gynecology & Obstetrics on September 20-21, 2018 at Toronto, Canada. .The conference is one of our yearly activities which have a goal of providing a setting for professionals in the respective field and our clients to learn about latest issues about health. The conference will have important Gynecology & Obstetrics experts around the world who will share the knowledge to the participants.
Excessive uterine bleeding is a common problem we see in gynecological practices and emergency rooms. It can interfere with women's daily activities and put them at risk for anemia and other more serious health consequences caused by blood loss," said Anita L. Nelson, MD, a LA BioMed lead investigator and corresponding author of the study. "Until now, there has been no Food and Drug Administration-approved products for short-term treatment of this condition. Based on our study, we conclude that this new progestogen-only treatment is effective in stopping acute abnormal uterine bleeding."
Within five days of receiving the therapy, bleeding had ceased in 44 of the 48 women in the study, and the other four were only experiencing spotting. The mean time to bleeding cessation was 2.6 days, leading the researchers to conclude the progestogen-only treatment was an effective short-term therapy for acute abnormal uterine bleeding.
Scientific Federation invites all the participants from all over the world to attend World Congress on Gynecology & Obstetrics during September 20-21, 2018 Toronto, Canada which includes Keynote presentations, Oral talks, Poster presentations and Exhibitions.
WCGO-2018 will also provide the excellent opportunity to meet experts, exchange information, and strengthen the collaboration among Directors, Researchers, Associate Professors, and Scholars from both academia and industry.

*P1
*P2
*P3
*P4
Gynecology
Fertility
Normal delivery
 Congress
Obstetrics
Pregnancy
Gynecological issues
World
Women health
Cesarean Delivery
Gynecological Oncology
Toronto
Reproductive Health
Reproductive Cancer
Caesarean Delivery Rates
Health
Reproductive Medicine
Obstetrical Care
Ultrasound in Obstetrics and Gynecology
Canada

URL - http://scientificfederation.com/gynecology-2018/   

0 comments:

Subscribe to: Posts (Atom)